Capital Intensity
Score how much of a company is physical plant, inventory, and equipment, whether that base is being maintained, and whether the shares have tangible backing.
Orthofix Medical Inc
Net PP&E was missing, so the physical footprint could not be scored. Capex is 0.42x depreciation and free cash flow yield is weak, which fits a cash drain on aging assets. EBITDA after capex covers debt service by -1.15x, which is below 1.
Physical asset ratio
—
Net PP&E plus inventory, divided by total assets. Above 50% is a heavy footprint.
Fixed asset turnover
—
Revenue per dollar of the physical asset base.
Capex / D&A
0.42x
Above 1.0x means the physical base is being replaced or expanded.
Tangible book / share
$4.57
Assets minus goodwill, intangibles, and liabilities, per share.
Price / tangible book
2.10x
Price $9.59.
Fixed-charge coverage
-1.15x
EBITDA minus capex, divided by interest plus short-term debt.
FCF yield
-0.3%
Latest free cash flow divided by current market cap ($387.64M).
ROIC
—
After-tax operating income over equity plus debt minus cash.
Footprint and return
Turnover and reinvestment
| Year | Physical | FAT | Capex/D&A | TBV/sh | Coverage | FCF | ROIC | EBIT/PP&E |
|---|---|---|---|---|---|---|---|---|
| 2018 | 25.6% | 10.58x | 0.82x | $11.16 | 31.75x | $34.66M | 6.8% | 0.70x |
| 2019 | 29.3% | 7.33x | 0.72x | $10.70 | -8.18x | $11.51M | — | -0.30x |
| 2020 | 28.2% | 6.39x | 0.50x | $10.95 | 3.79x | $57.18M | — | -0.10x |
| 2021 | 29.8% | 7.84x | 0.59x | $10.81 | 0.29x | -$1.12M | — | -0.14x |
| 2022 | 34.5% | 7.91x | 0.72x | $10.85 | -2.10x | -$34.70M | — | -0.23x |
| 2023 | 41.2% | 4.69x | 1.02x | $7.80 | -14.32x | -$107.80M | — | -0.87x |
| 2024 | 36.9% | 5.72x | 0.46x | $5.49 | -1.54x | -$9.09M | — | -0.61x |
| 2025 | — | — | 0.42x | $4.57 | -1.15x | -$1.28M | — | — |
- Principal due is short-term debt, the amount reported as due within a year.
Latest year inputs (2025)
Net PP&E: —
Inventory: $34.17M
Total assets: $850.65M
Goodwill: $194.93M
Intangibles: $72.77M
Liabilities: $400.61M
Tangible book: $182.34M
Shares: 39,883,000
Revenue: $822.31M
Capex: $34.63M
D&A: $83.26M
EBITDA: $9.93M
Interest: $17.49M
Short-term debt: $3.98M
Free cash flow: -$1.28M
Operating income: -$68.47M
Invested capital: $597.27M
Tax rate: —